841TiPA randomized phase II study comparing cabazitaxel/prednisone to cabazitaxel alone for second-line chemotherapy in men with metastatic castrate resistant prostate cancer (mCRPC): CABACARE
Buonerba, C.; Bosso, D.; De Placido, S.; Di Lorenzo, G.
- 期刊名称Annals of Oncology
- 作者Buonerba, C.; Bosso, D.; De Placido, S.; Di Lorenzo, G.
- 卷第28卷
- 印刷ISSN0923-7534
- 电子ISSN1569-8041
- 文件大小60.17KB
- 发表时间2017-09-01
- DOI10.1093/annonc/mdx370.058